Bio-Technology Facility Phase I
Undisclosed location (NDA)
The client, a market leader in the development and manufacture of bio-diagnostic products, was fast outgrowing their existing converted premises and we were tasked with designing a customised facility.
The new development houses the main production areas along with associated offices and support staff with a layout that will facilitate FDA/ISO approval alongside compliance with all relevant British Standards and Building Regulations.
The functionality and logic of the buildings layout is complemented by an external envelope that utilises many modern cladding techniques and systems with a close attention to a level of detail that reflects the clinical nature of the clients work.
Officially Inaugurated by HRH The Princess Royal on the 10th of April 2018.